Last updated: June 4, 2026
Chloraprep Triple Swabstick Suppliers: Who Manufactures, Supplies, and Distributes This Antiseptic Swab
Executive summary: Chloraprep Triple Swabstick is an antiseptic product line marketed in the U.S. by Integra LifeSciences and manufactured by CareFusion legacy entities (now part of BD/Integra ecosystem via acquisitions). The commercial “supplier” chain is dominated by the brand holder (Integra/CareFusion-origin manufacturing), with third-party distributors selling through surgical, hospital, and procurement channels. No substitute active-antiseptic “Triple Swabstick” is identical without matching formulation and packaging.
Who supplies Chloraprep Triple Swabstick to hospitals and wholesalers?
Direct brand supply chain
- Brand holder / marketer (U.S.): Integra LifeSciences (Chloraprep product line branding and distribution).
- Legacy manufacturer (acquired ecosystem): CareFusion (CareFusion produced Chloraprep and related swab products prior to corporate restructurings; the manufacturing responsibility is retained within the consolidated Integra/BD-linked corporate supply chain over time).
Distribution channels
- Wholesalers (typical U.S. hospital procurement intermediaries): major healthcare distributors sell Integra-branded antiseptic swabs to facilities under standard GPO and contract arrangements.
- Hospital group purchasing organizations (GPOs): Chloraprep supply is commonly accessed through national and regional GPO contracts, which set pricing and eligible SKU sourcing.
What to verify in procurement
- NDC and labeled dosage form (Chloraprep swab formats vary by application: 3-stick, single-stick, larger applicators).
- Sterility and packaging format (sealed single-use sticks).
- Label language and manufacturer statement on the carton insert.
What companies manufacture Chloraprep Triple Swabstick?
Primary manufacturing entity
- CareFusion-origin manufacturing remains the core production source for Chloraprep swabs (including multi-stick formats). The corporate lineage is tied to Integra LifeSciences through ownership and product portfolio transitions.
Corporate consolidation impacts
- Corporate restructuring has shifted responsibilities from “CareFusion” to current operating company names in labels and commercial documents, but the underlying Chloraprep product manufacturing is concentrated within the legacy Chloraprep manufacturing network rather than outsourced to many equivalent suppliers.
How manufacturers are reflected on packaging
- Look for the “Manufactured for” or “Distributed by” line and the “Manufacturer” line on the outer carton and blister/foil packaging, which often includes the current legal entity even if the product heritage is CareFusion.
Which antiseptic active ingredients and swab components define Chloraprep Triple Swabstick supply?
Chloraprep swabs are chlorhexidine gluconate-based antiseptic applicators used for skin preparation.
Supplier relevance
- Supply of the product is constrained by sourcing and validation of:
- Chlorhexidine gluconate raw material and solution concentration.
- Swabstick substrates (nonwoven fibers used for controlled wetting).
- Solvent/binder system that maintains antiseptic contact time and consistent delivery from stick to skin.
- Packaging materials that maintain shelf stability and sterility status where applicable.
Are there equivalent “triple swabstick” suppliers or generic antiseptic alternatives?
No one-to-one equivalence
- “Chloraprep Triple Swabstick” is a specific multi-stick format with branded formulation and device assembly standards.
- Market alternatives usually differ by:
- Active ingredient system (chlorhexidine vs povidone-iodine vs other antiseptics).
- Stick geometry and number of components.
- Contact time claims and label indications.
What matters for substitution
- If a facility switches to an alternative, procurement should require:
- Matching antiseptic concentration and active ingredient system.
- Matching intended use language (skin antisepsis prior to injection or surgery).
- Matching packaging format (multi-stick system if protocol requires it).
How does the supplier chain work in the U.S. for Chloraprep swabs?
Regulatory status drives supply
- Chloraprep is an antiseptic product; distribution is set through standard pharmaceutical/medical supply compliance rather than biologics pathways.
Operational flow (typical)
- Manufacturer produces bulk and finished swabs.
- Finished goods are packaged with NDC-labeled cartons and unit swabs.
- Brand holder controls distribution to GPO/wholesaler accounts.
- Wholesalers and GPO contract channels fulfill hospital purchase orders.
- Hospital inventory is replenished using contracted lead times.
Procurement friction points
- Packaging SKU differences and seasonal contract updates can change lead times even when manufacturers remain constant.
What does Orange Book list for Chloraprep Triple Swabstick?
Orange Book is not the controlling source for most antiseptic swabs
- Chloraprep triple swabsticks are antiseptic skin preparation products, and these are not typically “drug products” that appear in the FDA’s Orange Book listing system in the way prescription systemic drugs do.
- The practical compliance record used by procurement is usually FDA drug listing data (if applicable) and labeling/NDC identity, not Orange Book exclusivity.
What patent or exclusivity constraints affect suppliers of Chloraprep Triple Swabstick?
Supplier constraints are usually not patent-driven
- Antiseptic swabs rely heavily on formulation, device assembly, and regulatory labeling, but broad multi-year supplier exclusivity is less determinative than for complex therapeutics.
- In practice, supply bottlenecks are driven by:
- manufacturing capacity
- raw material availability
- contract distribution channels
- packaging/label SKU requirements
Supplier risks for Chloraprep Triple Swabstick: what procurement teams monitor
Common risk categories
- Manufacturing capacity changes within the consolidated CareFusion-origin and Integra-controlled network.
- Packaging SKU continuity, including carton NDC variants and triple-stick configuration changes.
- Distribution constraints through wholesaler allocation when inventories tighten.
Mitigation used in facilities
- Multi-source procurement that allows protocol-consistent antiseptic substitutes.
- Maintaining buffer stock for surgical service lines with predictable usage.
Chloraprep Triple Swabstick vs alternatives: how supplier equivalence is evaluated
Decision matrix for procurement
- Active ingredient: chlorhexidine system vs non-chlorhexidine antiseptics.
- Concentration and delivery: match to label instructions and clinical protocol.
- Swab format: triple-stick vs single-stick.
- Contact time and application method: protocol alignment.
- SKU and NDC: identity matching for formulary conversion.
- Distributor contract pricing: GPO eligibility and lead time.
Key supplier entities (summary list)
| Role |
Company/entity name |
What they do |
| Brand holder / marketer (U.S.) |
Integra LifeSciences |
Maintains Chloraprep product portfolio and distribution contracts |
| Legacy manufacturing origin |
CareFusion |
Produced Chloraprep and swab formats prior to corporate transitions |
| Downstream channel |
Major U.S. healthcare wholesalers (GPO-aligned) |
Provide inventory to hospitals under contract distribution |
Key Takeaways
- Chloraprep Triple Swabstick supply is anchored by the Integra LifeSciences brand and the CareFusion-origin manufacturing ecosystem.
- Hospitals typically access product through GPO and major wholesaler distribution, not through multiple competing manufacturers of identical triple-stick chlorhexidine applicators.
- “Supplier” equivalence for procurement depends on matching active ingredient system, swab format, and NDC-labeled identity, not merely “triple swab” wording.
- Substitution risk is operational and clinical, with alternatives often differing in antiseptic chemistry and application protocol.
FAQs
1) Which NDC should procurement match for Chloraprep Triple Swabstick?
Match the exact carton NDC and unit presentation shown in your formulary. Triple-stick formats may have multiple NDCs by packaging size.
2) Are there FDA-registered alternative “triple swab” antiseptics?
Alternatives exist, but they are usually not identical in active ingredient system and are evaluated for protocol-level equivalence.
3) Who typically distributes Chloraprep Triple Swabstick to hospitals in the U.S.?
It is commonly fulfilled through GPO-aligned healthcare wholesalers under Integra distribution agreements.
4) Can hospitals substitute a different antiseptic if Chloraprep is out of stock?
Substitution is typically handled via formulary protocol changes and requires verification of active ingredient, concentration, and skin preparation indication.
5) Does Chloraprep Triple Swabstick have Orange Book exclusivity?
Orange Book listings are generally not the primary framework for antiseptic swab devices; procurement relies on labeled identity and distribution compliance.
References (APA)
- Integra LifeSciences. Chloraprep product information and labeling (company product pages and package inserts).
- FDA. NDC Directory and product labeling resources.
- FDA. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations.
